NO20012308L - Kombinasjon av riluzol og alfatokoferol - Google Patents

Kombinasjon av riluzol og alfatokoferol

Info

Publication number
NO20012308L
NO20012308L NO20012308A NO20012308A NO20012308L NO 20012308 L NO20012308 L NO 20012308L NO 20012308 A NO20012308 A NO 20012308A NO 20012308 A NO20012308 A NO 20012308A NO 20012308 L NO20012308 L NO 20012308L
Authority
NO
Norway
Prior art keywords
combination
riluzole
alphatocopherol
benzothiazole
trifluoromethoxy
Prior art date
Application number
NO20012308A
Other languages
English (en)
Other versions
NO328349B1 (no
NO20012308D0 (no
Inventor
Michel Dib
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20012308L publication Critical patent/NO20012308L/no
Publication of NO20012308D0 publication Critical patent/NO20012308D0/no
Publication of NO328349B1 publication Critical patent/NO328349B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO20012308A 1998-11-13 2001-05-10 Kombinasjon av riluzol og α-tokoferol, anvendelse av denne og et farmasoytisk preparat omfattende en slik kombinasjon NO328349B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814250A FR2785808B1 (fr) 1998-11-13 1998-11-13 Association riluzole et alpha-tocopherol
PCT/FR1999/002753 WO2000028992A1 (fr) 1998-11-13 1999-11-09 Association riluzole et alpha-tocopherol

Publications (3)

Publication Number Publication Date
NO20012308L true NO20012308L (no) 2001-05-10
NO20012308D0 NO20012308D0 (no) 2001-05-10
NO328349B1 NO328349B1 (no) 2010-02-01

Family

ID=9532674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012308A NO328349B1 (no) 1998-11-13 2001-05-10 Kombinasjon av riluzol og α-tokoferol, anvendelse av denne og et farmasoytisk preparat omfattende en slik kombinasjon

Country Status (23)

Country Link
US (2) US6642262B2 (no)
EP (1) EP1128829B1 (no)
JP (1) JP4693241B2 (no)
KR (1) KR100641472B1 (no)
CN (1) CN1177587C (no)
AT (1) ATE295168T1 (no)
AU (1) AU776242B2 (no)
BR (1) BR9915292A (no)
CA (1) CA2350671C (no)
CZ (1) CZ298808B6 (no)
DE (1) DE69925301T2 (no)
DK (1) DK1128829T3 (no)
EA (1) EA003671B1 (no)
ES (1) ES2239858T3 (no)
FR (1) FR2785808B1 (no)
HK (1) HK1041220B (no)
HU (1) HU226067B1 (no)
IL (1) IL142708A0 (no)
NO (1) NO328349B1 (no)
PT (1) PT1128829E (no)
TR (1) TR200101346T2 (no)
WO (1) WO2000028992A1 (no)
ZA (1) ZA200103810B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786101B1 (fr) * 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
US20090149518A1 (en) * 2005-10-18 2009-06-11 Ono Pharmaceutical Co., Ltd. Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
US20070099156A1 (en) * 2005-10-28 2007-05-03 Jeff Wagner Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr) * 2010-03-02 2012-04-13 Univ Dauvergne Clermont I Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) * 2013-03-15 2014-09-18 Baylor College Of Medicine Msp and its receptors in the therapy of amyotrophic lateral sclerosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) * 1996-07-05 2002-04-30 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) * 1996-08-21 1998-07-14 Brooks; Benjamin Rix Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) * 1997-02-10 2007-03-07 龍兒 梶 筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) * 1998-08-07 2003-04-25 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
CN1326348A (zh) 2001-12-12
BR9915292A (pt) 2001-08-07
DE69925301D1 (de) 2005-06-16
CA2350671A1 (fr) 2000-05-25
DE69925301T2 (de) 2006-01-26
HK1041220B (zh) 2005-07-22
US20030125363A1 (en) 2003-07-03
KR20010080407A (ko) 2001-08-22
EP1128829B1 (fr) 2005-05-11
JP4693241B2 (ja) 2011-06-01
US20020019426A1 (en) 2002-02-14
ZA200103810B (en) 2002-08-12
EP1128829A1 (fr) 2001-09-05
NO328349B1 (no) 2010-02-01
TR200101346T2 (tr) 2002-05-21
AU776242B2 (en) 2004-09-02
US6642262B2 (en) 2003-11-04
ES2239858T3 (es) 2005-10-01
FR2785808B1 (fr) 2002-12-06
WO2000028992A1 (fr) 2000-05-25
ATE295168T1 (de) 2005-05-15
CN1177587C (zh) 2004-12-01
JP2002529506A (ja) 2002-09-10
CZ20011561A3 (cs) 2001-08-15
FR2785808A1 (fr) 2000-05-19
KR100641472B1 (ko) 2006-10-31
NO20012308D0 (no) 2001-05-10
IL142708A0 (en) 2002-03-10
CZ298808B6 (cs) 2008-02-06
HUP0105301A3 (en) 2006-07-28
HU226067B1 (en) 2008-04-28
EA200100530A1 (ru) 2001-10-22
HK1041220A1 (en) 2002-07-05
CA2350671C (fr) 2010-05-04
HUP0105301A2 (hu) 2002-05-29
AU1165500A (en) 2000-06-05
DK1128829T3 (da) 2005-08-29
PT1128829E (pt) 2005-07-29
EA003671B1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
NO954427D0 (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
DK1214936T3 (da) Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
DK0797439T3 (da) Anvendelse af pramipexol som et neurobeskyttende middel
GB9801690D0 (en) Therapeutic agents
EA199800667A1 (ru) Новые фенантридины
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
AU2093797A (en) Wood preservative for afterprotection
RS50071B (sr) Novi oblik soli pantoprazola
DK1468689T3 (da) 2-methyl-thieno-benzodiazepine formulation
NO20012308L (no) Kombinasjon av riluzol og alfatokoferol
AU5628800A (en) Substituted benzamide inhibitors of rhinovirus 3c protease
RS50002B (sr) Eletriptan hidrobromid monohidrat
CY1107343T1 (el) ΕΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ VIIa
PT941975E (pt) Cimento para injeccao contendo inibidores de corrosao
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
SE9704770D0 (sv) New use
AU6206698A (en) Isoflavone derivatives, processes for the preparation thereof and pharmac euticalcompositions containing them
MY140504A (en) Statin-mmp inhibitor combinations
SE9303060D0 (sv) Löstagbar stoppanordning
SE9302990D0 (sv) Anordning vid markberedning
IT1303825B1 (it) Corredo di strumenti per microchirurgia oftalmica.
BR7901395U (pt) Personalização de cadeiras de escritório e método para personalização de cadeiras de escritório

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees